Fast Five Quiz: Type 2 Diabetes and Cerebrovascular Disease

Romesh Khardori, MD, PhD, FACP


April 27, 2022

Hyperglycemia following an acute stroke is associated with worse clinical outcomes: growth of infarction and conversion to a hemorrhagic stroke. To treat hyperglycemia subcutaneous insulin on a sliding scale is the standard of care. The SHINE clinical trial demonstrated that intensive glucose control of hyperglycemia following an acute stroke did not result in a significant difference in favorable functional outcomes at 90 days compared with hyperglycemia managed with standard glucose control. In addition, patients who managed with intensive glucose control experienced more frequent episodes of hypoglycemia.

Continuous intravenous insulin is the standard of care in critically ill patients with diabetic ketoacidosis or hyperosmolar hyperglycemia.

Learn more about type 2 diabetes.

Editor's Recommendations


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.